CTRI/2023/09/057910尚未招募Unknown
Clinical validation of safety and efficacy of topical blend of herbal extracts in alleviating stress and improving mood in adults. - Nil
Sush Essentials Pvt. Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects meeting all of the following criteria will be eligible for the study:
- •1.Healthy male or female 25-55 years of age at the time of obtaining written informed consent
- •2.Subjects willing to sign inform consent form
- •3.A female participant who is of reproductive potential has a negative pregnancy test and agrees to use contraception throughout the study period
- •4.Subjects are free of anti-depressants /anti-anxiety/ mood enhancing/recreational drugs intake for at least one year at the start of the screening visit
- •5.Subjects are free of any ‘‘over the counter’’ or prescribed medications at the start of the screening visit
- •6.Subjects with a score of 7-26 on the Perceived Stress Scale (PSS)
- •7.Willing to abstain alcohol, caffeine, and nicotine consumption while in the study
- •8.No reported history of psychological or mental disorders.
- •9.Free of psychiatric conditions other than perceived stress
排除标准
- •Subjects meeting any of the following criteria will not be eligible for the study:
- •1.Resting systolic blood pressure above 140 mmHg or a diastolic blood pressure above 90 mmHg at baseline visit.
- •2.Taking any medicine or dietary supplements within the last 3 months to help to relieve sleep disturbances or physiological stress
- •3.History of substance abuse or dependence
- •4.Taking certain prohibited medications
- •5.Habitual smoking or vaping of products nicotine containing tetrahydrocannabinol (THC) with an average consumption >2 cigarettes or vaping more than 2 times per day
- •6.History of malignancy less than or equal to 5 years prior to signing an informed consent
- •7.Other conditions, which in the opinion of the investigators, makes the subject unsuitable for enrolment or could interfere with his/her participation in, and completion of the protocol.
- •8.Any known allergy or intolerance to any of the ingredients contained in supplements
研究者
相似试验
进行中(未招募)
1 期
ocalized neuropathic pain: topical treatment versus systemic treatmentEUCTR2018-003617-17-BEAntwerp University Hospital (UZA)591
招募中
4 期
Study of the effects of two eyedrops, Nepafenac and Flurbiprofen in reducing pain and inflammation in patients who are undergoing cataract surgery.CTRI/2017/01/007737Dr Saiyadali Allisabanavar80
尚未招募
3 期
Comparison of effectiveness and safety of Topical clindamycin vs minocycline vs ozenoxacin in patients of Acne vulgarisCTRI/2024/03/064118OT APPLICABLE
招募中
2 期
Comparative study between the creams Ozenoxacin and Nadifloxacin in facial AcneCTRI/2024/01/061760ENDLURU SASIKALA
尚未招募
不适用
A Comparative Study on efficacy and safety of topical 2% clotrimazole cream daily twice application with oral fluconazole and topical 1% Piroctone olamine daily night application with oral fluconazole teice per week for total of 4 weeks in the treatment of extensive dermatophytosisCTRI/2022/10/046904Department of DV
